CORDIS Project
Funding breakdown and partner intelligence are Premium
Sign in and upgrade to Premium for EU contribution totals, consortium analytics, OpenAlex research context, and AI summaries. · 0 consortium intelligence fields visible of 1
Start free • Cancel anytime • 14-day refund guarantee
AutoCRAT aims to create sustainable cell therapies for osteoarthritis by using human induced pluripotent stem cells to generate cartilage-repairing cells. This project addresses the need for effective treatments for osteoarthritis, which affects millions in Europe.
AutoCRAT will develop novel sustainable cell and cell-derived therapies for osteoarthritis (OA).
Osteoarthritis, a major disease, results in degradation of cartilage.
It is the most common chronic joint condition, currently affecting >40 million Europeans.
As no effective treatments for OA are available, it imposes a huge burden on the individual patient and European health care systems.
Adult mesenchymal stem/stromal cells (MSCs) show early, promising clinical treatment efficacy in OA.
However,…
UNIVERSITY OF GALWAY
Partner organizations (coordinator is shown above), with normalized type and CORDIS activity type. Guests see up to 4 partners.
Italy, Genova
Type: University / higher education
Activity type: Higher or Secondary Education Establishments
SME: No
Leiden University Medical Center
Netherlands, Leiden
Type: University / higher education
Activity type: Higher or Secondary Education Establishments
SME: No
UGOT - GOETEBORGS UNIVERSITET/UNIVERSITY OF GOTHENBURG
Sweden, Goeteborg
Type: University / higher education
Activity type: Higher or Secondary Education Establishments
SME: No
Similar projects, consortium collaboration history, frequent partners, and OpenAlex research context.
Guests see up to 5 EuroSciVoc fields.
Guests see up to 5 topics.
Guests see up to 5 keywords.
